IBDEI17K ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,21384,1,3,0)
 ;;=3^Thrombolytic Art/Ven Therapy
 ;;^UTILITY(U,$J,358.3,21385,0)
 ;;=37229^^117^1330^44^^^^1
 ;;^UTILITY(U,$J,358.3,21385,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21385,1,2,0)
 ;;=2^37229
 ;;^UTILITY(U,$J,358.3,21385,1,3,0)
 ;;=3^Tib/Per Revasc w/ Ather
 ;;^UTILITY(U,$J,358.3,21386,0)
 ;;=37230^^117^1330^46^^^^1
 ;;^UTILITY(U,$J,358.3,21386,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21386,1,2,0)
 ;;=2^37230
 ;;^UTILITY(U,$J,358.3,21386,1,3,0)
 ;;=3^Tib/Per Revasc w/ Stent
 ;;^UTILITY(U,$J,358.3,21387,0)
 ;;=37231^^117^1330^47^^^^1
 ;;^UTILITY(U,$J,358.3,21387,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21387,1,2,0)
 ;;=2^37231
 ;;^UTILITY(U,$J,358.3,21387,1,3,0)
 ;;=3^Tib/Per Revasc w/ Stent & Ather
 ;;^UTILITY(U,$J,358.3,21388,0)
 ;;=37232^^117^1330^50^^^^1
 ;;^UTILITY(U,$J,358.3,21388,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21388,1,2,0)
 ;;=2^37232
 ;;^UTILITY(U,$J,358.3,21388,1,3,0)
 ;;=3^Tib/Per Revasc,Add-on
 ;;^UTILITY(U,$J,358.3,21389,0)
 ;;=37233^^117^1330^45^^^^1
 ;;^UTILITY(U,$J,358.3,21389,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21389,1,2,0)
 ;;=2^37233
 ;;^UTILITY(U,$J,358.3,21389,1,3,0)
 ;;=3^Tib/Per Revasc w/ Ather,Add-On
 ;;^UTILITY(U,$J,358.3,21390,0)
 ;;=37234^^117^1330^49^^^^1
 ;;^UTILITY(U,$J,358.3,21390,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21390,1,2,0)
 ;;=2^37234
 ;;^UTILITY(U,$J,358.3,21390,1,3,0)
 ;;=3^Tib/Per Revasc w/ Stent,Add-On
 ;;^UTILITY(U,$J,358.3,21391,0)
 ;;=37235^^117^1330^48^^^^1
 ;;^UTILITY(U,$J,358.3,21391,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21391,1,2,0)
 ;;=2^37235
 ;;^UTILITY(U,$J,358.3,21391,1,3,0)
 ;;=3^Tib/Per Revasc w/ Stent & Ather,Add-On
 ;;^UTILITY(U,$J,358.3,21392,0)
 ;;=37215^^117^1330^53^^^^1
 ;;^UTILITY(U,$J,358.3,21392,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21392,1,2,0)
 ;;=2^37215
 ;;^UTILITY(U,$J,358.3,21392,1,3,0)
 ;;=3^Transcath Stent CCA w/ EPS
 ;;^UTILITY(U,$J,358.3,21393,0)
 ;;=37216^^117^1330^54^^^^1
 ;;^UTILITY(U,$J,358.3,21393,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21393,1,2,0)
 ;;=2^37216
 ;;^UTILITY(U,$J,358.3,21393,1,3,0)
 ;;=3^Transcath Stent CCA w/o EPS
 ;;^UTILITY(U,$J,358.3,21394,0)
 ;;=37188^^117^1330^55^^^^1
 ;;^UTILITY(U,$J,358.3,21394,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21394,1,2,0)
 ;;=2^37188
 ;;^UTILITY(U,$J,358.3,21394,1,3,0)
 ;;=3^Venous Mech Thrombectomy,Add-On
 ;;^UTILITY(U,$J,358.3,21395,0)
 ;;=93561^^117^1331^15^^^^1
 ;;^UTILITY(U,$J,358.3,21395,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21395,1,2,0)
 ;;=2^93561
 ;;^UTILITY(U,$J,358.3,21395,1,3,0)
 ;;=3^Thermal Dilution Study W/Cardiac Output
 ;;^UTILITY(U,$J,358.3,21396,0)
 ;;=93571^^117^1331^10^^^^1
 ;;^UTILITY(U,$J,358.3,21396,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21396,1,2,0)
 ;;=2^93571
 ;;^UTILITY(U,$J,358.3,21396,1,3,0)
 ;;=3^Intravascular Dopplar Add-On, First Vessel
 ;;^UTILITY(U,$J,358.3,21397,0)
 ;;=93572^^117^1331^11^^^^1
 ;;^UTILITY(U,$J,358.3,21397,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21397,1,2,0)
 ;;=2^93572
 ;;^UTILITY(U,$J,358.3,21397,1,3,0)
 ;;=3^Intravascular Dopplar, Each Addl Vessel
 ;;^UTILITY(U,$J,358.3,21398,0)
 ;;=93740^^117^1331^14^^^^1
 ;;^UTILITY(U,$J,358.3,21398,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21398,1,2,0)
 ;;=2^93740
 ;;^UTILITY(U,$J,358.3,21398,1,3,0)
 ;;=3^Temperature Gradient Studies
 ;;^UTILITY(U,$J,358.3,21399,0)
 ;;=93784^^117^1331^2^^^^1
 ;;^UTILITY(U,$J,358.3,21399,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,21399,1,2,0)
 ;;=2^93784
 ;;^UTILITY(U,$J,358.3,21399,1,3,0)
 ;;=3^Amb BP Monitor 24+ hrs,Int&Rpt
